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Abstract. We report the case of an Ebola virus (EBOV) RNA–negative pregnant woman who delivered an EBOV
RNA–positive stillborn infant at a community health center in rural Sierra Leone, 1 month after the mother’s last
possible exposure. The mother was later found to be immunoglobulins M and G positive indicating previous infection.
The apparent absence of Ebola symptoms and not recognizing that the woman had previous contact with an Ebola
patient led health workers performing the delivery to wear only minimal personal protection, potentially exposing them
to a high risk of EBOV infection. This case emphasizes the importance of screening for epidemiological risk factors
as well as classic and atypical symptoms of Ebola when caring for pregnant women, even once they have passed the
typical time frame for exposure and incubation expected in nonpregnant adults. It also illustrates the need for health-
care workers to use appropriate personal protection equipment when caring for pregnant women in an Ebola setting.
On January 13, 2015, the U.S. Centers for Disease Control
and Prevention (CDC) field laboratory in Bo, Sierra Leone,
identified Ebola virus (EBOV) RNA in an oral swab from a
stillborn infant by quantitative real-time reverse-transcription
polymerase chain reaction (qRT-PCR) for EbolaNP and VP40
genes. The swab, taken in accordance with Sierra LeoneMinistry
of Health and Sanitation (MoHS) protocol to investigate all
deaths regardless of symptoms or exposure during the outbreak,
tested positive with cycle threshold values of 16 in both targets,
indicating a high viral load. At the time of delivery, the infection
status of the mother was unknown.
A team from Médecins Sans Frontières (MSF) traveled to
the village where the infant was born to find the mother and
investigate the chain of transmission. The 20-year-old woman
was found healthy and living with her husband who had
been discharged from the MSF Ebola Management Center
(EMC) in Bo on December 16, 2014. Despite her insistence
that she had had no symptoms of Ebola virus disease (EVD),
she agreed to be tested for EBOV.
On January 15, a whole blood sample was collected from
the mother in the Bo Hospital Transit Center and analyzed
at the CDC field laboratory. The sample was negative for
both EBOV RNA targets. CDC laboratorians re-extracted
RNA and reran assays on the maternal and infant samples
with the same result. Later enzyme-linked immunosorbent
assays performed by CDC Atlanta on the maternal sample
to detect antibodies specific to Ebola found it positive for
immunoglobulin M (IgM, titer ≥ 1:1,600) and immunoglobu-
lin G (IgG, titer ≥ 1:400), indicating the mother had had a
recent EBOV infection (Table 1).1 Virus isolation attempts
with the infant swab were positive. Isolation was not attempted
with the maternal sample because of negative qRT-PCR and
positive IgM results.
To learn more about possible transmission routes for the
woman’s infection, an MSF team conducted separate qualita-
tive interviews with the woman and her husband in their
village (Figure 1). On December 3, 2014 the husband devel-
oped symptoms (vomiting, fatigue, loss of appetite, and head-
ache) after carrying his sick uncle to the community health
center 9 days earlier. The uncle, who spent only a few hours
in the pregnant woman’s house, died at the health center
shortly after arriving and was diagnosed EBOV positive using
RT-PCR testing of a postmortem oral swab.
The husband’s brother and a friend, who helped carry the
uncle to the health center but did not live with the couple or
the uncle, developed symptoms on December 3 and 4, respec-
tively. On December 6, all three men tested EBOV positive
(Table 1), and their households were quarantined for 21 days.
The brother died in the Transit Center; the husband and his
friend were admitted to the MSF EMC and discharged cured
on December 16 and 21, respectively. Both husband and wife
separately reported that they did not have sexual intercourse
on his return home, due to EMC health education, but also
because of the woman’s pregnancy.
The woman was approximately 7-month pregnant when her
husband became symptomatic. Although she did not sleep in
the same bed once he became ill, she did provide close contact
care for him, including bathing and massage. On January 21,
when CDC, MoHS, and World Health Organization officials
interviewed the woman using a standardized questionnaire to
collect information about potential symptoms of Ebola in the
month before onset of labor, she reported experiencing
intense fatigue and loss of appetite, abdominal pain, jaundice,
eye pain, sensitivity to light, and confusion. During the qualita-
tive interviews conducted by MSF on February 9, she reported
experiencing severe back pain and a “gush of water” from her
vagina on the day after her husband went to Bo (December 7),
leakage of bloody fluid from her vagina, loss of appetite, and
intense fatigue. But she did not describe the latter symptoms
noted in the standardized questionnaire and in the absence of
clinical opinion at the time, it is difficult to determine which
report is more accurate (Table 2).
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Since the woman associated her symptoms with pregnancy
and anxiety regarding her husband’s illness, she did not seek
medical care nor reveal her condition to anyone, including
the contact tracer. When her husband returned from the
EMC on December 15, the couple still did not believe any of
her symptoms were related to Ebola. They were also under
the impression that they could not seek medical care while
in quarantine. Thus, the woman only sought medical care
on December 28 after completing the 21-day quarantine. She
reported being treated for an infection and vaccinated
against tetanus and was told to return home until she was
closer to term. After walking 3 miles home, she told the vil-
lage traditional birth attendant (TBA) that the baby had
stopped moving. The TBA was unable to find a fetal heart-
beat and advised her to seek medical care again. She sought
care at a second health center where she was given medica-
tion, which the TBA believed was to induce labor.
On January 10, 2015, she went into labor, walked to the
health center where she had first sought care and delivered a
stillborn infant. The fetus was deformed and macerated. Since
the woman had no symptoms and was no longer in quaran-
tine, and because the fetus was already emerging when the
mother arrived, the nurse assisting wore minimal personal
protection equipment (PPE) consisting of gloves and an apron
during the delivery. The village TBA, who had accompanied
the woman, wore no PPE during the delivery. The nurse
followed MoHS guidelines and requested a safe burial for the
infant and an oral swab was collected. Once the stillborn
infant was identified as EBOV RNA positive, the nurse and
TBA were quarantined but did not develop any EVD symp-
toms during the 21-day period. No additional cases were
reported in the couple’s village or surrounding settlements
served by the health center.
To our knowledge, this is the first report of a delivery of an
EBOV-infected stillbirth in a rural community health center,
and the case raises a number of important issues about pro-
viding care for pregnant women outside an EMC setting
during an Ebola outbreak. Most notable is the increased risk
of exposure that occurs for health workers when clinical
symptoms are not reported, and they do not take into account
epidemiological indicators, such as previous contact with a
positive case, when assessing the risk of infection.
There is limited information about maternal and fetal out-
comes related to EBOV infection. Previous reports have
documented only pregnancies managed in an EMC setting,2–4
noting that pregnant women tend to have more severe disease
and worse outcomes than nonpregnant women. Mupapa and
others reported a case fatality rate of 95.5% among pregnant
women compared with 70% in nonpregnant women in an
Ebola outbreak in Kikwit, Democratic Republic of the Congo,
in 1995 and that the majority of the 15 EBOV-infected preg-
nant women presented with serious symptoms more often
than EBOV-infected nonpregnant women.2
Recently, Baggi and others highlighted the potential for
more positive outcomes, describing two symptomatic pregnant
women admitted to an EMC in Guinea who survived vaginal
delivery with supportive care. However, both delivered EBOV-
infected stillborn infants, and the authors warned of the pos-
sibility of pregnant EVD survivors being referred to local
health-care centers for delivery, potentially exposing maternity
staff to a high risk of infection.3
The case we describe did not become severely ill in the
way people in West Africa have come to expect of those suf-
fering from Ebola. The woman did not recognize her symp-
toms as being related to Ebola, nor did the health workers
who assisted her, despite miscarriage being a defining
TABLE 1
Test results for samples collected from persons in the chain of transmission, Bo, Sierra Leone, 2014–2015
Patient Specimen collection date Specimen source Ebola virus load result (CT value)* Other results
Wife January 15, 2015 Blood Negative (> 40:> 40) IgG positive (≥ 1:400)
IgM positive (≥ 1:1,600)
– Repeat† Negative (> 40:> 40) –
Stillborn Infant January 10, 2015 Oral swab Positive (16:16) –
– Repeat† Positive (20:19) –
Husband December 7, 2014 Blood Positive (28:28) –
Husband’s Brother December 7, 2014 Blood Positive (18:19) –
Husband’s Friend December 7, 2014 Blood Positive (26:26) –
Uncle November 24, 2014 Oral swab Positive (26:26) –
CT = cycle threshold; IgG = immunoglobulin M; IgM = immunoglobulin M.
*The first value corresponds with the NP gene and the second value corresponds with the VP40 gene.
†The sample from the infant and wife were retested on January 17, 2015.
FIGURE 1. Chains of transmission associated with an Ebola-positive stillborn infant, Bo District, Sierra Leone, November 2014 to January
2015.
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characteristic of Ebola during pregnancy. In the absence of the
more recognizable symptoms of Ebola (i.e., fever, vomiting,
and diarrhea), the woman’s symptoms were misinterpreted
as being caused by anxiety and pregnancy complications. We
must, however, also acknowledge the difficulty of knowing for
sure the clinical history of this case, given that fear of isolation
and stigmatization may have influenced what the woman was
willing to reveal.
The relatively long time between events and the assump-
tion that there was no risk after completing a 21-day quaran-
tine may also have reduced the alertness of the health
workers. We believe the mother was most likely infected
through contact with the uncle or with her husband after he
developed symptoms and not as a result of sexual contact
post recovery since the woman’s description of the start of
her intrauterine fetal death supports an earlier infection
date. The possibility of a long delay between fetal death and
delivery in EBOV-affected pregnancy has been previously
seen.6 An MSF technical guidance paper cites a woman
admitted to the EMC in her 5th month of pregnancy, who
had an EBOV-infected stillbirth 32 days after she tested RT-
PCR negative.
Although there is also scant information currently in the
literature about mild or asymptomatic EBOV infections,
Akerlund and others recently reported a case in Monrovia,
Liberia, of a pregnant woman with suspected premature rup-
ture of membranes who did not meet EVD case definition
or report an EVD contact but tested EBOV positive with a
high viral load 3 days before becoming symptomatic. Blood,
urine, oral, and vaginal fluids were all positive before the
onset of obvious EVD symptoms, leading the authors to sug-
gest that pregnancy might alter EVD presentation and pro-
gression and warn of the challenges this may present for
health-care workers.7
All these cases point to a critical requirement for health
workers, especially in the community where laboratory results
will rarely be available before care, to be informed that the
risk of EBOV transmission cannot be excluded even if the
pregnant woman does not appear to have symptoms and her
last known exposure to an EBOV-positive contact was more
than 21 days prior. It is also important that all pregnant
women who are EVD survivors or have been in contact with
a confirmed EVD case are followed until the end of their
pregnancy and encouraged to deliver in an appropriately pre-
pared health-care facility.
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TABLE 2
Symptoms reported by the subject during the case investigation com-
pared with Sierra Leone MoHS case definition5*
Standardized
questionnaire by
CDC/MoHS/WHO
on January 21
Qualitative interview
by MSF
investigation team
on February 9
Acute fever (> 38°C) No No
Headache No No
Abdominal pain Yes No
Intense fatigue Yes Yes
Loss of appetite Yes Yes
Generalized or articular pain No No
Difficulty in swallowing No No
Difficulty in breathing No No
Nausea or vomiting No No
Hiccups No No
Miscarriage No No
Diarrhea No No
Unexplained bleeding No Yes
CDC = Centers for Disease Control and Prevention; MoHS = Ministry of Health and
Sanitation; MSF = Médecins Sans Frontières; WHO = World Health Organization.
*A suspect case of Ebola is defined as contact with a clinical case and acute fever
(> 38°C), or contact with a clinical case and three or more of the above symptoms, or acute
fever and three or more of the concerning symptoms above, or any unexplained bleeding
or miscarriage.5
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